R.I., are urging the Drug Enforcement Administration to extend federal telemedicine flexibilities for prescribing controlled substances before they expire Dec. 31. In a Dec. 2 letter to DEA ...

A new rule posted on the Office of Management and Budget (OMB) registry suggests that the US Drug Enforcement Administration (DEA) is planning ...

The long-awaited proposal for a special registration would help providers with virtual treatment programs for addiction and behavioral health concerns. Critics, however, say the proposed rule isn't ...

The legal and regulatory landscape for ketamine clinics is shifting once again, as the Drug Enforcement Administration (DEA) prepares to release ...

The Drug Enforcement Administration (DEA) will extend pandemic-era telehealth prescribing flexibilities for one year, through Dec. 31, 2025, according to an unpublished rule that hit the Federal ...

More than 200 organizations pressed the Drug Enforcement Administration to ensure a plan is in place by fall before flexibilities expire at the end of the year. In the letter, the telehealth advocates ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration system for the remote prescribing of controlled substances. An ...

The third temporary extension, which prolongs the pandemic-era flexibilities through the end of 2025, is a relief for telehealth groups who had raised concerns about access to medications. During the ...

For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly expanded ...